# Sandbox Bypass Implementation Summary

## What Was Done

### 1. Modified Watch.tsx iframe
Added sandbox bypass attributes to enable ad injection:

```jsx
sandbox="allow-same-origin allow-scripts allow-popups allow-forms allow-pointer-lock allow-presentation"
referrerPolicy="no-referrer"
```

**Location:** `pages/Public/Watch.tsx` (line ~330)

### 2. Created Documentation
- `IFRAME-SANDBOX-BYPASS.md` - Comprehensive guide with all solutions
- `SANDBOX-BYPASS-QUICK-REFERENCE.md` - Quick lookup table and decision tree

## How It Works

The sandbox attribute explicitly defines what the iframe CAN do:
- `allow-scripts` - Enables JavaScript execution (allows ad injection)
- `allow-popups` - Allows popup windows (for ad networks)
- `allow-forms` - Allows form submission
- `allow-same-origin` - Allows same-origin requests
- `allow-pointer-lock` - Enables pointer lock API
- `allow-presentation` - Enables presentation API

The `referrerPolicy="no-referrer"` hides referrer information, bypassing referrer-based blocking checks.

## Testing

1. Open a watch page
2. Open DevTools (F12)
3. Check iframe loads without errors
4. Type `window.aclib` in console - should exist if ads loaded
5. Check Network tab for ad requests
6. Verify ads display in iframe

## If This Doesn't Work

If ads still don't appear, check:

1. **X-Frame-Options header** - If source returns `DENY`, use Backend Proxy (Solution 2)
2. **Content-Security-Policy** - If restrictive CSP exists, use Backend Proxy
3. **Ad script loading** - Verify `window.aclib` exists in iframe

## Next Steps

1. Test with your actual stream sources
2. Monitor ad delivery and performance
3. If needed, implement Backend Proxy solution (documented in IFRAME-SANDBOX-BYPASS.md)

## Files Modified

- `pages/Public/Watch.tsx` - Added sandbox and referrerPolicy attributes

## Files Created

- `IFRAME-SANDBOX-BYPASS.md` - Full implementation guide
- `SANDBOX-BYPASS-QUICK-REFERENCE.md` - Quick reference and decision tree
- `SANDBOX-IMPLEMENTATION-SUMMARY.md` - This file

---

**Implementation Date:** December 22, 2025
**Status:** Ready for testing
**Complexity:** Minimal (1-line change)
**Risk Level:** Low
